XJPX
4936
Market cap41mUSD
Oct 09, Last price
289.00JPY
1D
1.40%
1Q
-17.66%
IPO
-84.42%
Name
Axxzia Inc
Chart & performance
P/E
—
P/S
0.49
EPS
—
Div yield, %
3.51%
Shrs. gr., 5y
-1.16%
Rev. gr., 5y
18.40%
Revenues
13.47b
-0.10%
Net income
-465m
L
CFO
299m
-61.77%
Dividend
Jan 28, 20275 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AXXZIA Inc. manufactures and sells cosmetics and supplements in Japan. The company offers eyecare, skincare, supplements and drinks, salon care, hair care, hair styling, and beauty device products under the AXXZIA, AGtheory, LisBeau, LisBlanc, The B, Le Ciel de L'aube, Aither, NICE GLOW, Medullux, Venus Recipe, and RevWell brand names. It also provides products online. AXXZIA Inc. was incorporated in 2011 and is headquartered in Shinjuku, Japan.
Key people
Xiaowei Duan
Vice President, Director · since 2018
Ippei Mizota
Executive Officer, Director of Domestic Sales · since 2025
Zhihua Wang
Executive Officer, Senior Director of Sales · since 2023
Satoshi Takai
Executive Officer · since 2024
Yasuhito Fukui
Director · since 2019
Dan Taku
President, President of Subsidiary, Representative Director · since 2022
Jun Wu
Managing Director, Chairman of Subsidiaries · since 2023
Hui Zhang
Managing Director · since 2021
Yuujiro Arakawa
Independent Director · since 2019
Independent Director · since 2023
Yuko Shimomori
Independent Director · since 2024
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2026‑07 | 2025‑07 | 2024‑07 | 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||